Domain Not Resolving

Font Awesome

reCAPTCHA

jsDelivr

BootstrapCDN

reCAPTCHA v2

HSTS IncludeSubdomains PreLoad

Apache 2.4

Amazon S3

Amazon CloudFront

Chief Information Officer

Adam Wasylyshyn

Owner

Barry Harrison

Chief Commercial Officer

Bret Christensen

Senior Vice President and Chief Human Resources Officer

Dan Manea

Manager, Global Commercial Process Owner

Danielle Lazu

Chief Marketing Officer

Lei Mercado

Engineering

Robert Austin

Sam Morrissey

General Counsel

Tony Diehl

Executive Vice President and Chief Financial Officer

Wayde McMillan

Timothy J. Scannell

Shacey Petrovic

Hjalte Hojsgaard

Sr. Regional Business Director

President & Chief Executive Officer & Co-Founder

Jason Wills

Senior Consumer Marketing Manager, International

Lauren Budden

Group VP, Chief Accounting Officer & Controller

Alejandro Lagos

Sr. Software Engineer, Android

Ronda Williams

Territory Manager

Melissa Lee

Senior Manager, Instructional Design

Ana Maria Chadwick

Chief Financial Officer

New England Companies With More Than $100M in Revenue

East Coast Public Companies With More Than 500 Employees

Northeastern US Companies With More Than $50M in Revenue

Northeastern US Companies With More Than 1000 Employees

Insulet is a medical device company improving the lives of people with diabetes and other conditions through its omnipod delivery system.  The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage.

OrbiMed

Series E - Insulet

Acton

Massachusetts

United States

North America

Insulet

Insulet to expand with 110 new jobs in Mass., as Watertown life sciences firm looks to add 20

Why Insulet Stock Was Zooming Higher This Week

FDA clears its first automated insulin pump for Type 2 diabetes with Insulet's Omnipod 5

Insulet Opens New Malaysian Manufacturing Facility

Insulet inventory pressures cloud annual revenue forecast raise

Insulet's prelim Q2 revenue tops estimates

Why Is Omnipod Insulin Device Maker Insulet Stock Jumping Today?

Insulet Data Backs Omnipod 5 for Type 2 Diabetes, Seeks Expanded FDA OK

Insulet builds type 2 diabetes case

Insulet Fully Rolls Out Omnipod 5 with Dexcom G7 in U.S., Launches iPhone App

United Kingdom

Europe

India

Asia

Ethiopia

Africa

The Netherlands

HTML5

Vimeo

Google Fonts

Amazon EC2

F5 NGINX

Office 365

Microsoft Outlook

Google Tag Manager

Google Analytics

jQuery

Insulet owns Insulet

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Insulet Corporation

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 8, 2024 2:09 PM	b348c673
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 2:09 PM	4bed22a7
company summary	general
signals	general
crunchbase trigger	general	Oct 30, 2024 1:02 PM	92a882f2
crunchbase profile	general	Oct 30, 2024 11:39 PM	73a20e04
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	811d83f6
peers	general
news basic	general	Mar 8, 2024 2:09 PM	fe7d1bee
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:INSULET

Insulet Corporation

Last Close

262.00

22/11 21:00

Market Cap

13.84B

Beta: -

Volume Today

443.96K

Avg: -